RITA AZZO: Open Payments
NPI 1841718517 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,850 in 87 payments from 17 companies in 2025. Trend: 2023 $2,086 · 2024 $2,586 · 2025 $1,850
Food & beverage: $1,850
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 28 | $406 |
| Amgen Inc. | 12 | $359 |
| ABBVIE INC. | 16 | $335 |
| Janssen Biotech, Inc. | 6 | $211 |
| PFIZER INC. | 4 | $88 |
| GlaxoSmithKline, LLC. | 4 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| Octapharma USA, Inc. | 2 | $57 |
| Lilly USA, LLC | 2 | $47 |
| Radius Health, Inc. | 2 | $43 |
Products named: KRYSTEXXA, Bimzelx, RINVOQ, TREMFYA, OCTAGAM IMMUNE GLOBULIN (HUMAN), BENLYSTA, Cimzia, SKYRIZI.
Industry payments across FL — which companies pay providers there.
